Finance

Lists
OCGN:NASDAQ
Ocugen Inc
$1.02
-3.76%
(-0.040) 1D
Sep 10, 2:56:45 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OCGN...
Open
$1.10
High
$1.10
Low
$1.01
Mkt. cap
345.96M
Avg. vol.
5.02M
Volume
19.48M
52-wk high
$2.72
52-wk low
$1.01
EPS
-$0.25
Beta
2.20
Shares outstanding
339.11M
No. of employees
116
Open
$1.10
High
$1.10
Low
$1.01
Mkt. cap
345.96M
Avg. vol.
5.02M
Volume
19.48M
52-wk high
$2.72
52-wk low
$1.01
EPS
-$0.25
Beta
2.20
Shares outstanding
339.11M
No. of employees
116
News stories
From web sources and news partners
About Ocugen Inc
CEOShankar Musunuri
Employees116
Founded2013
HeadquartersMalvern, Pennsylvania, United States
SectorBiotechnology
Websiteocugen.com
Analyst ratings
Based on 4 analysts giving stock ratings to OCGN in the past 3 months
Strong buy
Buy
4
Hold
0
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for OCGN in the last 3 months.
Highest
Current $1.02
$12.00 (+1,070.73%)
Average
$10.13 (+888.29%)
Lowest
$8.00 (+680.49%)
Analyst
Recommendation
Action
Price target
Projected
Date
Robert LeBoyer
Noble Financial
Buy
Reiterated
$12.00
+1,070.7%
09/10/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$11.00
+973.2%
09/10/2026
Swayampakula Ramakanth
H.C. Wainwright
Buy
Maintained
$9.50
+826.8%
09/10/2026
Michael Okunewitch
Maxim Group
Buy
Reiterated
$8.00
+680.5%
08/10/2026
Daniil Gataulin
Chardan Capital
Buy
Reiterated
$7.00
+582.9%
05/07/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$10.00
+875.6%
05/06/2026
Elemer Piros
Lucid Capital
Buy
Maintained
$22.00
+2,046.3%
03/11/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
1.75M
-193.00K
1.53M
1.49M
Cost of goods sold
11.15M
10.67M
11.26M
10.69M
Cost of revenue
11.15M
10.67M
11.26M
10.69M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.23M
6.13M
8.12M
7.24M
Operating expense
8.23M
6.13M
8.12M
7.24M
Total operating expenses
19.38M
16.80M
19.37M
17.93M
Operating income
-17.62M
-17.00M
-17.84M
-16.44M
Other non operating income
-1.32M
477.00K
-150.00K
-1.97M
EBT including unusual items
-20.05M
-17.71M
-19.18M
-24.88M
EBT excluding unusual items
-20.05M
-17.71M
-19.18M
-22.49M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-20.05M
-17.71M
-19.18M
-24.88M
Net profit margin
-1,144.46%
9,174.09%
-1,250.95%
-1,671.84%
Earnings per share
-0.07
-0.06
-0.06
-0.06
Interest and investment income
207.00K
144.00K
132.00K
395.00K
Interest expense
-1.31M
-1.33M
-1.32M
-4.48M
Net interest expenses
-1.11M
-1.19M
-1.19M
-4.08M
Depreciation and amortization charges
-
-
-
-
EBITDA
-16.68M
-16.40M
-17.25M
-15.86M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps